SLC22A3 and esophageal squamous cell carcinoma: ADAR2 is overexpressed in familial normal esophageal tissues, which increases the A-to-I RNA editing of the SLC22A3 gene and reduces the expression of the SLC22A3 gene, thereby increasing the susceptibility of ESCC (Fu et al., 2017).